Abdala vaccine candidate: 92.28% efficacy in its three doses
Center for Genetic Engineering and Biotechnology (CIGB). Photo: Pinterest. The Center for Genetic Engineering and Biotechnology (CIGB) announced this Monday in Havana that the Cuban Abdala vaccine candidate has an efficacy of 92.28% with a scheme of three applied doses, according to the clinical studies of the immunogen. With Read more